Transitional Care and Discharge of Patients with COPD: Improving Practice to Reduce Readmissions Webcast
Release Date: May 28, 2015
Expiration Date: May 28, 2016
Sidney Braman, MD
Professor of Medicine
Pulmonary, Critical Care, and Sleep Medicine
Icahn School of Medicine at Mount Sinai
New York, New York
Joshua LaBrin, MD, FACP, SFHM
Assistant Clinical Professor
University of Utah School of Medicine
Salt Lake City, Utah
Although chronic obstructive pulmonary disease (COPD) is a treatable disease in its early stages, most individuals experience progressive loss of lung function that leads to more frequent and severe symptoms and hospitalizations. Patients who are highly susceptible to exacerbations, or at high risk, require individualized discharge and transitional care plans that account for the specific characteristics and severity of their disease.
Hospital-based healthcare providers are extremely well situated to have a major impact on the care of these patients. With this important responsibility comes the need for hospital physicians to be highly skilled at evaluating patients with COPD based on their risk for recurrent exacerbations and tailoring their management plans at discharge. The goal of this program is to improve the knowledge, competence, and performance of hospital clinicians, so that these objectives may be achieved.
This educational initiative has been designed for hospital‐based healthcare providers involved in the management of patients with COPD.
Upon completion of this educational activity, participants should be able to:
- Assess future risk for worsening disease and exacerbations in patients with COPD to prevent hospital readmission
- Provide individualized discharge and transitional care plans for patients at high risk who were recently hospitalized for COPD
Directions to Learner
There are no fees for participating and receiving CME credit for this activity. During the period May 28, 2015 through May 28, 2016, participants must:
- Read the learning objectives and faculty disclosures
- Complete the pretest
- Study the educational activity
- Complete the posttest by recording the best answer to each question in the answer key on the evaluation form
- Complete the evaluation form
A statement of credit will be issued upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Your statement of credit will be sent to you within 4 weeks.
Accreditation Council for Continuing Medical Education Accreditation Statement
Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Integrity Continuing Education designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest (COI)
Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Sidney Braman, MD
Royalties: AP Press, Guilford Press
Joshua LaBrin, MD, FACP, SFHM, hereby states that he or his spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Patima Tanapat, PhD, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Sunovion Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. and Sunovion Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
When you participate in an online educational activity sponsored by Integrity CE, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and...(continued)
Minimum System Requirements
Windows XP, Windows 2000, Windows Vista, and Windows 7
Intel Pentium 4, 2.33 + GHz (or equivalent)
Adobe® Flash® Player 10
For optimal performance, the use of Internet Explorer is not recommended.
Mac OS X v10.4 or later
1.8GHz or faster (or equivalent)
Intel Core Duo 1.33GHz or faster (or equivalent)
Adobe® Flash® Player 10
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.
|Sponsored by Integrity Continuing Education, Inc.|
|Supported by an educational grant from Sunovion Pharmaceuticals, Inc.|
Normal 0 false false false MicrosoftInternetExplorer4